PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Nov-2024 Modus Therapeutics Receives Approval to Initiate a Phase IIa Clinical Trial for Chronic Kidney Disease (CKD) Modus Therapeutics
19-Nov-2024 PHIOGEN announces collaboration with Live UTI Free to drive patient-focused clinical trials PHIOGEN
19-Nov-2024 Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain Resolution Therapeutics
19-Nov-2024 Women’s Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment Freya Biosciences
19-Nov-2024 Theolytics Doses First Patient in Phase I/IIa Trial of THEO-260 in Ovarian Cancer Theolytics
19-Nov-2024 Cytomos secures £5M to scale up production of cell-analysis technology Cytomos
19-Nov-2024 Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer Nouscom
19-Nov-2024 Scintil Photonics names Matt Crowley as CEO, founder Sylvie Menezo will continue heading technology developments and customer partnerships Andrew Lloyd Associates
19-Nov-2024 PLL Therapeutics obtains authorization to start phase I/II trial in Australia for patients with Amyotrophic Lateral Sclerosis (ALS)  Andrew Lloyd Associates
19-Nov-2024 LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab AccessWire
19-Nov-2024 New Partnership: Bioz Helps DNA Polymerase Technology to Boost Research Visibility Through Interactive Citation Badges AccessWire
19-Nov-2024 Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001 Thermosome
19-Nov-2024 M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets M1 Kliniken AG
19-Nov-2024 Kuros Biosciences Expands into Extremities Markets AccessWire
19-Nov-2024 Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried AG
19-Nov-2024 Kuros Biosciences Expands into Extremities Markets Kuros Biosciences AG
19-Nov-2024 Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences Formycon AG
18-Nov-2024 Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member AccessWire
18-Nov-2024 Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor AccessWire
18-Nov-2024 aap Implantate AG: EBITDA guidance raised aap Implantate AG